Engineering poliovirus as a vaccine vector for the expression of diverse antigens
- PMID: 8073288
- DOI: 10.1126/science.8073288
Engineering poliovirus as a vaccine vector for the expression of diverse antigens
Abstract
As a step toward developing poliovirus as a vaccine vector, poliovirus recombinants were constructed by fusing exogenous peptides (up to 400 amino acids) and an artificial cleavage site for viral protease 3Cpro to the amino terminus of the viral polyprotein. Viral replication proceeded normally. An extended polyprotein was produced in infected cells and proteolytically processed into the complete array of viral proteins plus the foreign peptide, which was excluded from mature virions. The recombinants retained exogenous sequences through successive rounds of replication in culture and in vivo. Infection of animals with recombinants elicited a humoral immune response to the foreign peptides.
Similar articles
-
Toward a poliovirus-based simian immunodeficiency virus vaccine: correlation between genetic stability and immunogenicity.J Virol. 1997 Oct;71(10):7841-50. doi: 10.1128/JVI.71.10.7841-7850.1997. J Virol. 1997. PMID: 9311872 Free PMC article.
-
Poliovirus recombinants expressing hepatitis B virus antigens elicited a humoral immune response in susceptible mice.Virology. 1996 Apr 1;218(1):61-70. doi: 10.1006/viro.1996.0166. Virology. 1996. PMID: 8615042
-
Foot-and-mouth disease virus 2A protease mediates cleavage in attenuated Sabin 3 poliovirus vectors engineered for delivery of foreign antigens.J Virol. 1996 Nov;70(11):8124-7. doi: 10.1128/JVI.70.11.8124-8127.1996. J Virol. 1996. PMID: 8892938 Free PMC article.
-
Vaccines based on recombinant antigen strategies.Dev Biol (Basel). 2001;105:189-94. Dev Biol (Basel). 2001. PMID: 11763327 Review. No abstract available.
-
Approaches to the construction of new candidate poliovirus type 3 vaccine strains.Dev Biol Stand. 1993;78:161-9; discussion 169-70. Dev Biol Stand. 1993. PMID: 8388827 Review.
Cited by
-
Genetically stable picornavirus expression vectors with recombinant internal ribosomal entry sites.J Virol. 2002 Sep;76(17):8966-72. doi: 10.1128/jvi.76.17.8966-8972.2002. J Virol. 2002. PMID: 12163617 Free PMC article.
-
Novel design architecture for genetic stability of recombinant poliovirus: the manipulation of G/C contents and their distribution patterns increases the genetic stability of inserts in a poliovirus-based RPS-Vax vector system.J Virol. 2002 Feb;76(4):1649-62. doi: 10.1128/jvi.76.4.1649-1662.2002. J Virol. 2002. PMID: 11799160 Free PMC article.
-
Mucosal immunity: overcoming the barrier for induction of proximal responses.Immunol Res. 2004;30(1):35-71. doi: 10.1385/IR:30:1:035. Immunol Res. 2004. PMID: 15258310 Review.
-
Attenuated Mengo virus: a new vector for live recombinant vaccines.J Virol. 1995 May;69(5):3193-6. doi: 10.1128/JVI.69.5.3193-3196.1995. J Virol. 1995. PMID: 7707549 Free PMC article.
-
Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection.J Virol. 2001 Mar;75(5):2377-87. doi: 10.1128/JVI.75.5.2377-2387.2001. J Virol. 2001. PMID: 11160741 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials